CME Group has filed suit against the CFTC, arguing the regulator improperly approved Kalshi’s perpetual futures contracts. The case could shape how U.S. watchdogs classify and oversee perps.
CME Chief Executive Terrence Duffy said the exchange operator plans to challenge the CFTC’s approval of perpetual futures products. He argued the products may fall under swap rules rather than futures under Dodd-Frank.
